Additionally, novel strategies aimed at enhancing gallbladder motility in insulin-resistant states provide another avenue for therapeutic intervention, collectively suggesting multiple pathways for developing more effective treatments for patients with concurrent MetS and GSD. Here, INS is linked to disorder of glycogen metabolism.